Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 14 de 14
Filter
Add more filters










Publication year range
1.
Gene ; 761: 145036, 2020 Nov 30.
Article in English | MEDLINE | ID: mdl-32777525

ABSTRACT

Lupinus albus γ-conglutin is proposed to positively affect glucose metabolism through inhibition of hepatic glucose production and insulin-mimetic activity; however, the action mechanism is not entirely known. Besides, most studies had focused on its effect on molecular targets directly related to glucose metabolism, and few studies have investigated how γ-conglutin may affect the liver gene expression or if it plays a role in other metabolic processes. Therefore, we investigated the influence of γ-conglutin on the liver transcriptome of streptozotocin-induced diabetic rats using DNA microarrays, ontological analyses, and quantitative PCR. Of the 22,000 genes evaluated, 803 and 173 were downregulated and upregulated, respectively. The ontological analyses of the differentially expressed genes revealed that among others, the mitochondria, microtubules, cytoskeleton, and oxidoreductase activity terms were enriched, implying a possible role of γ-conglutin on autophagy. To corroborate the microarray results, we selected and quantified, by PCR, the expression of two genes associated with autophagy (Atg7 and Snx18) and found their expression augmented two and threefold, respectively; indicating a higher autophagy activity in animals treated with γ-conglutin. Although complementary studies are required, our findings indicate for the first time that the hypoglycaemic effects of γ-conglutin may involve an autophagy induction mechanism, a pivotal process for the preservation of cell physiology and glucose homeostasis.


Subject(s)
Collectins/pharmacology , Lupinus/metabolism , Serum Globulins/pharmacology , Transcriptome/genetics , Animals , Blood Glucose/metabolism , Collectins/metabolism , Collectins/physiology , Diabetes Mellitus, Experimental/chemically induced , Diabetes Mellitus, Experimental/metabolism , Diabetes Mellitus, Type 2/metabolism , Glucose/metabolism , Insulin/metabolism , Liver/metabolism , Liver/pathology , Lupinus/genetics , Male , Plant Proteins/genetics , Rats , Rats, Wistar , Seeds/metabolism , Serum Globulins/metabolism , Serum Globulins/physiology
2.
J Immunol Res ; 2019: 9164202, 2019.
Article in English | MEDLINE | ID: mdl-31482100

ABSTRACT

Collectin-12 (collectin placenta 1, CL-P1, or CL-12) is a newly identified pattern recognition molecule of the innate immune system. Recent evidences show that CL-12 plays important roles not only in innate immune protection against certain clinically important pathogens but also in scavenging of host molecules, leukocyte recruitment, and cancer metastasis. Furthermore, CL-12 has been shown to be associated with the pathogenesis of human diseases such as Alzheimer's disease and multiple sclerosis lesion development. Therefore, the functional consequence of CL-12 remains intriguing and awaits further elucidation. However, available protocols for the purification of recombinant CL-12 with high purity are laborious and inefficient and hamper further functional studies. Here, we report a simple, rapid, and efficient solution to obtain biologically active CL-12 with high purity. We established stable transfected Flp-In™-CHO cells expressing the recombinant CL-12 extracellular domain in high amounts. Recombinant CL-12 was purified from cell culture supernatants using a 3-step rapid purification procedure utilizing disposable affinity and ion exchange minicolumns. Purified recombinant CL-12 adopted an oligomeric structure with monomers, dimers, and trimers and retained its binding capacity towards the A. fumigatus strain that has been described before. Furthermore, we demonstrated the opsonic properties towards eight clinical isolates of A. fumigatus strains and diverse clinically important fungal pathogens. Purified recombinant CL-12 revealed a differential binding capacity towards selected fungal pathogens in vitro. In conclusion, we demonstrate a rapid and efficient purification solution for further biochemical and functional characterization of CL-12 and reveal opsonic properties of CL-12 towards diverse fungal pathogens.


Subject(s)
Aspergillus fumigatus/immunology , Collectins/isolation & purification , Opsonin Proteins/isolation & purification , Receptors, Scavenger/isolation & purification , Animals , Aspergillus fumigatus/metabolism , CHO Cells , Collectins/genetics , Collectins/metabolism , Collectins/pharmacology , Cricetulus , Humans , Opsonin Proteins/genetics , Opsonin Proteins/metabolism , Opsonin Proteins/pharmacology , Receptors, Scavenger/genetics , Receptors, Scavenger/metabolism
3.
J Am Soc Nephrol ; 29(1): 168-181, 2018 01.
Article in English | MEDLINE | ID: mdl-29142050

ABSTRACT

Collectin-11 is a recently described soluble C-type lectin, a pattern recognition molecule of the innate immune system that has distinct roles in host defense, embryonic development, and acute inflammation. However, little is known regarding the role of collectin-11 in tissue fibrosis. Here, we investigated collectin-11 in the context of renal ischemia-reperfusion injury. Compared with wild-type littermate controls, Collec11 deficient (CL-11-/- ) mice had significantly reduced renal functional impairment, tubular injury, renal leukocyte infiltration, renal tissue inflammation/fibrogenesis, and collagen deposition in the kidneys after renal ischemia-reperfusion injury. In vitro, recombinant collectin-11 potently promoted leukocyte migration and renal fibroblast proliferation in a carbohydrate-dependent manner. Additionally, compared with wild-type kidney grafts, CL-11-/-mice kidney grafts displayed significantly reduced tubular injury and collagen deposition after syngeneic kidney transplant. Our findings demonstrate a pathogenic role for collectin-11 in the development of tubulointerstitial fibrosis and suggest that local collectin-11 promotes this fibrosis through effects on leukocyte chemotaxis and renal fibroblast proliferation. This insight into the pathogenesis of tubulointerstitial fibrosis may have implications for CKD mediated by other causes as well.


Subject(s)
Cell Proliferation/drug effects , Chemotaxis, Leukocyte/genetics , Collectins/genetics , Collectins/pharmacology , Kidney Tubules/pathology , Nephritis/genetics , Allografts/pathology , Animals , Chemotaxis, Leukocyte/drug effects , Collagen/metabolism , Collectins/metabolism , Extracellular Matrix/metabolism , Fibroblasts/physiology , Fibrosis , Kidney Transplantation , Kidney Tubules/metabolism , Male , Mice , Mice, Knockout , Nephritis/etiology , Nephritis/pathology , Nephritis/physiopathology , Reperfusion Injury/complications , Reperfusion Injury/pathology
4.
Pol J Vet Sci ; 15(3): 455-62, 2012.
Article in English | MEDLINE | ID: mdl-23214364

ABSTRACT

In the present study we investigated the effect of bovine conglutinin on the phagocytic activity of leukocytes. We measured both the chemotactic activity of conglutinin and its effect on the internalization of zymosan particles and E. coli by granulocytes. We also assessed the binding of conglutinin to various microorganisms isolated from clinical cases in cattle. We showed that conglutinin binds strongly to the surface of yeast cells and to mannan-rich zymosan particles, while weak binding was observed in the case of the bacterial strains tested, including those whose O antigen is composed of mannan. Conglutinin (1-10 microg/ml) neither acts as a chemotactic factor for peripheral blood leukocytes nor affects ingestion of E. coli by granulocytes. However, as flow cytometry based assay showed, conglutinin (0.1-1 microg/ml) increased ingestion of zymosan expressed as mean fluorescence intensity (MFI) of positive cells.


Subject(s)
Collectins/pharmacology , Granulocytes/drug effects , Phagocytosis/drug effects , Serum Globulins/pharmacology , Animals , Bacteria , Candida albicans , Cattle , Chemotaxis/drug effects , Dose-Response Relationship, Drug , Granulocytes/physiology , Humans , Phagocytosis/physiology , Protein Binding , Zymosan/chemistry
5.
J Vet Sci ; 13(1): 33-8, 2012 Mar.
Article in English | MEDLINE | ID: mdl-22437533

ABSTRACT

Conglutinin is a high molecular-weight lectin originally detected in bovine serum. It belongs to the family of collectins that bind sugar residues in a Ca(2+)-dependent manner and are effector molecules in innate immunity. Conglutinin appears to play an important role in immune defense mechanisms, showing antiviral and antibacterial activities when tested in vivo and in vitro. The present study evaluated the effect of conglutinin on the respiratory bursts in bovine peripheral phagocytes. Using nitroblue tetrazolium and hydrogen peroxide assays, we showed that sugar ligand-bound conglutinin stimulated the production of superoxide and H2O2 in granulocytes whereas the non-sugar-bound form of conglutinin inhibited these processes. These results indicate that both forms of conglutinin are able to interact with surface leukocyte receptors but have opposite effects on phagocytic activity. Our findings suggest that conglutinin bound to sugar residues on microbial surfaces can induce oxygen burst in phagocytes, and thereby mediates the elimination of pathogens and prevents the spread of infection.


Subject(s)
Cattle/immunology , Collectins/pharmacology , Granulocytes/drug effects , Reactive Oxygen Species/immunology , Respiratory Burst/drug effects , Serum Globulins/pharmacology , Animals , Enzyme-Linked Immunosorbent Assay/veterinary , Female , Granulocytes/immunology , Hydrogen Peroxide/immunology , Immunity, Innate/drug effects , Immunity, Innate/immunology , Phagocytosis/immunology , Respiratory Burst/immunology , Statistics, Nonparametric , Superoxides/immunology
6.
Article in English | WPRIM (Western Pacific) | ID: wpr-13095

ABSTRACT

Conglutinin is a high molecular-weight lectin originally detected in bovine serum. It belongs to the family of collectins that bind sugar residues in a Ca(2+)-dependent manner and are effector molecules in innate immunity. Conglutinin appears to play an important role in immune defense mechanisms, showing antiviral and antibacterial activities when tested in vivo and in vitro. The present study evaluated the effect of conglutinin on the respiratory bursts in bovine peripheral phagocytes. Using nitroblue tetrazolium and hydrogen peroxide assays, we showed that sugar ligand-bound conglutinin stimulated the production of superoxide and H2O2 in granulocytes whereas the non-sugar-bound form of conglutinin inhibited these processes. These results indicate that both forms of conglutinin are able to interact with surface leukocyte receptors but have opposite effects on phagocytic activity. Our findings suggest that conglutinin bound to sugar residues on microbial surfaces can induce oxygen burst in phagocytes, and thereby mediates the elimination of pathogens and prevents the spread of infection.


Subject(s)
Animals , Female , Cattle/immunology , Collectins/pharmacology , Enzyme-Linked Immunosorbent Assay/veterinary , Granulocytes/drug effects , Hydrogen Peroxide/immunology , Immunity, Innate/drug effects , Phagocytosis/immunology , Reactive Oxygen Species/immunology , Respiratory Burst/drug effects , Serum Globulins/pharmacology , Statistics, Nonparametric , Superoxides/immunology
7.
Scand J Immunol ; 72(1): 22-30, 2010 Jul.
Article in English | MEDLINE | ID: mdl-20591072

ABSTRACT

Collectins contribute to host defence through interactions with glycoconjugates on pathogen surfaces. We have prepared recombinant trimeric neck and carbohydrate recognition domains (NCRD) of collectins, and we now show that the NCRD of bovine conglutinin and CL-46 (like that of CL-43) have greater intrinsic antiviral activity for influenza A virus (IAV) than the human SP-D NCRD (hSP-D-NCRD). The three serum collectins differ from SP-D by having insertions adjacent to amino acid 325 and substitution of hydrophobic residues for arginine 343. We previously showed that a three amino acid (RAK) insertion, as found in CL-43, increases antiviral activity and mannan-binding activity of the hSP-D-NCRD, while the substitution of valine at 343, as in conglutinin, more strongly increased these activities. Mannan-binding activity of collectins has been considered to predict for ability to bind to high mannose glycans on viruses or other pathogens. We now show, however, that combined mutants containing the RAK insertion and R343V or R343I substitutions have greatly increased mannan-binding ability, but lower IAV binding or inhibiting activity than mutants containing R343V or R343I substitutions only. These findings indicate differences in the recognition of glycan structures of mannan and IAV by the NCRD and emphasize the importance of the flanking sequences in determining the differing interactions of human SP-D and bovine serum collectins with mannose-rich glycoconjugates on IAV and other pathogens. Of interest, we show conservation of some monoclonal antibody-binding epitopes between bovine collectin NCRD and hSP-D, suggesting shared structural motifs.


Subject(s)
Collectins/pharmacology , Influenza A virus/immunology , Influenza, Human/immunology , Mannans/immunology , Pulmonary Surfactant-Associated Protein D/pharmacology , Amino Acid Motifs , Cell Line , Collectins/genetics , Collectins/immunology , Enzyme-Linked Immunosorbent Assay , Hemagglutination Inhibition Tests , Humans , Influenza, Human/drug therapy , Influenza, Human/virology , Pulmonary Surfactant-Associated Protein D/genetics , Pulmonary Surfactant-Associated Protein D/immunology , Recombinant Proteins/genetics , Recombinant Proteins/immunology , Recombinant Proteins/pharmacology
8.
Arch Virol ; 152(9): 1731-42, 2007.
Article in English | MEDLINE | ID: mdl-17514488

ABSTRACT

The collectins, lung surfactant proteins A and D (SP-A and SP-D), contribute to innate host defense against influenza A virus (IAV) in vivo. Although collectins bind to the viral hemagglutinin (HA) and inhibit early stages of viral infection in vitro, they also bind to the neuraminidase (NA) and inhibit NA activity. We used a variety of NA functional assays, viral strains and recombinant (mutant or wild type) collectins to characterize the mechanism of NA inhibition. NA inhibition by SP-D correlates with binding of its carbohydrate recognition domain (CRD) to oligomannose oligosaccharides on the viral hemagglutinin (HA). The effects of SP-D are additive with oseltamivir, consistent with differences in mechanism of action. NA inhibition was observed using fetuin or MDCK cells as a substrate, but not in assays using a soluble sialic acid analogue. Collectin multimerization and CRD binding properties are key determinants for NA inhibition. SP-D had greater NA inhibitory activity than mannose-binding lectin, which in turn had greater activity than SP-A. The markedly greater NA inhibitory activity of SP-D compared to SP-A may partly account for the finding that deletion of the SP-D gene in mice has a greater effect on viral replication in vivo.


Subject(s)
Collectins/pharmacology , Influenza A virus/drug effects , Neuraminidase/antagonists & inhibitors , Pulmonary Surfactant-Associated Protein D/immunology , Animals , Antiviral Agents/pharmacology , Chickens , Influenza A virus/immunology , Mice , Neuraminidase/metabolism , Pulmonary Surfactant-Associated Protein D/metabolism
9.
J Vet Med Sci ; 69(2): 221-4, 2007 Feb.
Article in English | MEDLINE | ID: mdl-17339771

ABSTRACT

Mannan-binding lectin (MBL) and bovine conglutinin (BKg) belong to the collectin family, which is involved in first-line host defense against various infectious agents. We have previously reported that human MBL inhibited type A influenza viral hemagglutination, infection and spreading to adjacent cells without complement activation. In this study, we investigated the direct antiviral activities of bovine MBL, rabbit MBL and BKg. All collectins used in this study inhibited viral infectivity and hemagglutination at concentrations of 0.02-0.3 microg/ml. They also demonstrated inhibitory activity against viral spreading. Like human MBL, bovine MBL and BKg showed antiviral activities at their physiological concentrations. These results suggest that mammalian MBLs and BKg may inhibit the spread of influenza A virus through the bloodstream.


Subject(s)
Collectins/pharmacology , Influenza A Virus, H3N2 Subtype/growth & development , Influenza, Human/drug therapy , Mannose-Binding Lectin/pharmacology , Serum Globulins/pharmacology , Animals , Cattle , Cell Line , Dogs , Hemagglutination Inhibition Tests , Humans , Influenza, Human/metabolism , Influenza, Human/virology , Rabbits
10.
Biochemistry ; 45(8): 2679-85, 2006 Feb 28.
Article in English | MEDLINE | ID: mdl-16489761

ABSTRACT

We have reported that Gram-negative organisms decorated with rough lipopolysaccharide (LPS) are particularly susceptible to the direct antimicrobial actions of the pulmonary collectins, surfactant proteins A (SP-A) and D (SP-D). In this study, we examined the lipid and LPS components required for the permeabilizing effects of the collectins on model bacterial membranes. Liposomes composed of 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine (POPE), with or without rough Escherichia coli LPS (J5), smooth E. coli LPS (B5), or cholesterol, were loaded with self-quenching probes and exposed to native or oxidatively modified SP-A. Fluorescence that resulted from permeabilization of liposomes and diffusion of dyes was assessed by microscopy or fluorimetry. Human SP-A and melittin increased the permeability of J5 LPS/POPE liposomes, but not B5 LPS/POPE liposomes or control (POPE only) liposomes. At a human SP-A concentration of 100 microg/mL, the permeability of the J5 LPS/POPE membranes increased 4.4-fold (p < 0.02) compared to the control with no added SP-A. Rat SP-A and SP-D also permeabilized the J5-containing liposomes. Incorporation of cholesterol into J5 LPS/POPE liposomes at a POPE:cholesterol molar ratio of 1:0.15 blocked human SP-A or melittin-induced permeability (p < 0.05) compared to cholesterol-free liposomes. Exposure of human SP-A to surfactant lipid peroxidation blocked the permeabilizing activity of the protein. We conclude that SP-A permeabilizes phospholipid membranes in an LPS-dependent and rough LPS-specific manner, that the effect is neither SP-A- nor species-specific, and that oxidative damage to SP-A abolishes its membrane destabilizing properties. Incorporation of cholesterol into the membrane enhances resistance to permeabilization by SP-A, most likely by increasing the packing density and membrane rigidity.


Subject(s)
Cell Membrane Permeability/drug effects , Collectins/pharmacology , Lipopolysaccharides/metabolism , Lung/metabolism , Animals , Calcium/metabolism , Calcium/pharmacology , Cholesterol/metabolism , Cholesterol/pharmacology , Collectins/metabolism , Escherichia coli/metabolism , Fluorescent Dyes/metabolism , Humans , Lipid Peroxidation/drug effects , Lipopolysaccharides/pharmacology , Liposomes/metabolism , Models, Biological , O Antigens/metabolism , O Antigens/pharmacology , Phosphatidylethanolamines/metabolism , Pulmonary Surfactant-Associated Protein A/metabolism , Pulmonary Surfactant-Associated Protein A/pharmacology , Pulmonary Surfactant-Associated Protein D/metabolism , Pulmonary Surfactant-Associated Protein D/pharmacology , Rats
11.
J Biol Chem ; 278(38): 36250-6, 2003 Sep 19.
Article in English | MEDLINE | ID: mdl-12857753

ABSTRACT

Histoplasma capsulatum (Hc) is a facultative intracellular fungal pathogen that causes acute and chronic pneumonia. In this study, we investigated the role of the pulmonary collectins, surfactant proteins (SP) A and D, in the clearance of Hc yeast from the lung. Exposure of yeast to either collectin induced a dose-dependent decrease in [3H]leucine incorporation by several strains of Hc. This decrement was attributed to killing of the collectin-exposed yeast since it failed to grow on agar medium. Exposure to SP-A or -D resulted in increased yeast permeability based on a leak of protein from the organism and enhanced access of an impermeant substrate to intracellular alkaline phosphatase. Inbred and outbred SP-A null (-/-) mice were modestly more susceptible to pulmonary infection with Hc than strain and age-matched SP-A (+/+) control mice. The increase in susceptibility was associated with a decrement in the number of CD8+ cells in the lungs of SP-A-/- mice. Neither SP-A nor SP-D inhibited the growth of macrophage-internalized Hc. We conclude that the SP-A and SP-D are antimicrobial proteins that directly inhibit the growth of Hc by increasing permeability of the organism and that Hc gains asylum from collectin-mediated killing by rapid entry into pulmonary macrophages.


Subject(s)
Lung/cytology , Lung/microbiology , Macrophages/metabolism , Agar/pharmacology , Alkaline Phosphatase/metabolism , Alleles , Animals , Cell Division , Collectins/pharmacology , Dose-Response Relationship, Drug , Flow Cytometry , Histoplasma/metabolism , Humans , Leukocytes/microbiology , Lung/metabolism , Mice , Mice, Inbred C3H , Mice, Transgenic , Pulmonary Surfactant-Associated Protein A/physiology , Pulmonary Surfactant-Associated Protein D/physiology , Rats , Rats, Sprague-Dawley , Recombinant Proteins/chemistry , Spleen/metabolism , Stem Cells/metabolism , Time Factors
12.
Am J Physiol Lung Cell Mol Physiol ; 285(4): L854-61, 2003 Oct.
Article in English | MEDLINE | ID: mdl-12794007

ABSTRACT

The phagocytosis of apoptotic inflammatory cells by alveolar macrophages (AMs) is a key component of inflammation resolution within the air space. Surfactant protein A (SP-A) has been shown to stimulate the phagocytosis of apoptotic neutrophils (PMNs) by normal AMs. We hypothesized that SP-A promotes the resolution of alveolar inflammation by enhancing apoptotic PMN phagocytosis and anti-inflammatory cytokine release by inflammatory AMs. Using an LPS lung inflammation model, we determined that SP-A stimulates the phagocytosis of apoptotic PMNs threefold by normal AMs and AMs isolated after LPS injury. Furthermore, SP-A enhances transforming growth factor-beta1 (TGF-beta1) release from both AM populations. Inflammatory AMs release twofold more TGF-beta1 in culture than do normal AMs. SP-A and apoptotic PMNs together stimulate TGF-beta1 release equivalently from normal and inflammatory cultured AMs (330% of unstimulated release by normal AMs). In summary, SP-A enhances apoptotic PMN uptake, stimulates AM TGF-beta1 release, and modulates the amount of TGF-beta1 released when AMs phagocytose apoptotic PMNs. These findings support the hypothesis that SP-A promotes the resolution of alveolar inflammation.


Subject(s)
Apoptosis/physiology , Macrophages, Alveolar/metabolism , Neutrophils/physiology , Phagocytosis , Pneumonia/metabolism , Pulmonary Surfactant-Associated Protein A/physiology , Pulmonary Surfactants , Transforming Growth Factor beta/metabolism , Acute Disease , Animals , Apoptosis/drug effects , Cells, Cultured , Collectins/pharmacology , Humans , Jurkat Cells , Lipopolysaccharides/pharmacology , Macrophages, Alveolar/drug effects , Male , Opsonin Proteins/pharmacology , Phagocytosis/drug effects , Pneumonia/chemically induced , Pneumonia/pathology , Pneumonia/physiopathology , Pulmonary Surfactant-Associated Protein A/pharmacology , Pulmonary Surfactants/pharmacology , Rats , Rats, Sprague-Dawley , Transforming Growth Factor beta1
13.
J Clin Invest ; 111(10): 1589-602, 2003 May.
Article in English | MEDLINE | ID: mdl-12750409

ABSTRACT

The pulmonary collectins, surfactant proteins A (SP-A) and D (SP-D), have been reported to bind lipopolysaccharide (LPS), opsonize microorganisms, and enhance the clearance of lung pathogens. In this study, we examined the effect of SP-A and SP-D on the growth and viability of Gram-negative bacteria. The pulmonary clearance of Escherichia coli K12 was reduced in SP-A-null mice and was increased in SP-D-overexpressing mice, compared with strain-matched wild-type controls. Purified SP-A and SP-D inhibited bacterial synthetic functions of several, but not all, strains of E. coli, Klebsiella pneumoniae, and Enterobacter aerogenes. In general, rough E. coli strains were more susceptible than smooth strains, and collectin-mediated growth inhibition was partially blocked by coincubation with rough LPS vesicles. Although both SP-A and SP-D agglutinated E. coli K12 in a calcium-dependent manner, microbial growth inhibition was independent of bacterial aggregation. At least part of the antimicrobial activity of SP-A and SP-D was localized to their C-terminal domains using truncated recombinant proteins. Incubation of E. coli K12 with SP-A or SP-D increased bacterial permeability. Deletion of the E. coli OmpA gene from a collectin-resistant smooth E. coli strain enhanced SP-A and SP-D-mediated growth inhibition. These data indicate that SP-A and SP-D are antimicrobial proteins that directly inhibit the proliferation of Gram-negative bacteria in a macrophage- and aggregation-independent manner by increasing the permeability of the microbial cell membrane.


Subject(s)
Cell Membrane Permeability/drug effects , Gram-Negative Bacteria/drug effects , Pulmonary Surfactant-Associated Protein A/pharmacology , Pulmonary Surfactant-Associated Protein D/pharmacology , Animals , Bacterial Outer Membrane Proteins/genetics , Bronchoalveolar Lavage Fluid/chemistry , Bronchoalveolar Lavage Fluid/microbiology , Cell Division/drug effects , Collectins/pharmacology , Dactinomycin/pharmacokinetics , Escherichia coli/drug effects , Escherichia coli/genetics , Escherichia coli/metabolism , Escherichia coli Infections/drug therapy , Escherichia coli Infections/metabolism , Fluorescent Dyes/pharmacokinetics , Genetic Predisposition to Disease , Gram-Negative Bacteria/genetics , Gram-Negative Bacteria/metabolism , Humans , Mice , Mice, Inbred C3H , Mice, Knockout , Microbial Sensitivity Tests , Pulmonary Surfactant-Associated Protein A/deficiency , Pulmonary Surfactant-Associated Protein A/genetics , Pulmonary Surfactant-Associated Protein D/biosynthesis , Pulmonary Surfactant-Associated Protein D/genetics , Rats , Rats, Sprague-Dawley , Respiratory Tract Infections/drug therapy , Respiratory Tract Infections/metabolism
14.
Infect Immun ; 70(11): 6129-39, 2002 Nov.
Article in English | MEDLINE | ID: mdl-12379690

ABSTRACT

Collectins play important roles in host defense against infectious microorganisms. We now demonstrate that the serum collectins mannose-binding lectin (MBL) and conglutinin have less ability to bind to, aggregate, and enhance neutrophil uptake of several strains of gram-negative and gram-positive bacteria than pulmonary surfactant protein D (SP-D). Collectins are composed of four major structural domains (i.e., N-terminal, collagen, and neck and carbohydrate recognition domains). To determine which domains of SP-D are responsible for its greater bacterial binding or aggregating activity, activities of chimeric collectins containing the N-terminal and collagen domains of SP-D coupled to the neck recognition domains and carbohydrate recognition domains (CRD) of MBL or conglutinin (SP-D/Cong(neck+CRD) and SP-D/MBL(neck+CRD)) were tested. The SP-D/Cong(neck+CRD) and SP-D/MBL(neck+CRD) chimeras bound to and aggregated the bacteria more strongly than did wild-type MBL or conglutinin. SP-D/MBL(neck+CRD) also enhanced neutrophil uptake of bacteria more so than MBL. Hence, the SP-D N-terminal and/or collagen domains contribute to the enhanced bacterial binding and aggregating activities of SP-D. In prior studies, SP-D/Cong(neck+CRD) and SP-D/MBL(neck+CRD) had increased ability to bind to influenza virus compared not only with that of conglutinin or MBL but with that of wild-type SP-D as well. In contrast, the chimeras had either reduced or unchanged ability to bind to or aggregate bacteria compared to that of wild-type SP-D. Hence, although replacement of the neck recognition domains and CRDs of SP-D with those of MBL and conglutinin conferred increased viral binding activity, it did not favorably affect bacterial binding activity, suggesting that requirements for optimal collectin binding to influenza virus and bacteria differ.


Subject(s)
Bacteria/immunology , Phagocytosis/drug effects , Pulmonary Surfactant-Associated Protein D/pharmacology , Animals , Collagen/pharmacology , Collectins/pharmacology , Humans , Mannose-Binding Lectin/pharmacology , Neutrophils/drug effects , Neutrophils/immunology , Pulmonary Surfactant-Associated Protein D/chemistry , Pulmonary Surfactant-Associated Protein D/metabolism , Rats , Recombinant Fusion Proteins/pharmacology , Recombinant Proteins/pharmacology , Serum Globulins/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...